Germany, Feb. 19 -- Project Id: 68615
Description: Grant agreement ID: 823126
Status
Ongoing project
Start date
1 August 2018
End date
31 July 2020
Funded under:
H2020-EU.3. , H2020-EU.2.3. , H2020-EU.2.1.
Overall budget:
€ 2 630 270
EU contribution
€ 1 841 189
Objective
TETUS will address commercialisation complexities related to cell products and prepares MukoCell(R) for accelerated commercialisation by facilitating an EU-wide Market Authorisation. As MukoCell(R) addresses an unmet medical need, it is eligible to use an EU-accelerated market access pathway. Once Marketing Authorisation is in place, country-specific reimbursement strategies and market access (financial) plans can be developed that are requirments...